首页> 外文期刊>Journal of Dairy Science >Our Industry Today: Efficacy of Parenterally or Intramammarily Administered Tilmicosin Or Ceftiofur Against Staphylococcus aureus Mastitis During Lactation
【24h】

Our Industry Today: Efficacy of Parenterally or Intramammarily Administered Tilmicosin Or Ceftiofur Against Staphylococcus aureus Mastitis During Lactation

机译:当今我们的行业:胃肠外或乳房内施用替米考星或头孢噻呋对泌乳期金黄色葡萄球菌乳腺炎的功效

获取原文
获取原文并翻译 | 示例
       

摘要

Two antibiotic preparations, tilmicosin and ceftiofur, were tested intramammarily and parenter- ally against Staphylococcus aureus mastitis in lactat- ing cows. Neither product was effective as a lactating cow treatment at he doses and durations of treat- ment tested, Injection or infusion of tilmicosin and infusion of ceftiofur resulted in reductions of bacteria present in milk; however, only one quarter treated with infusion of tilmicosin was cured, and no cures were observed for the other treatments.
机译:在泌乳母牛的乳房内和胃肠外对两种抗生素制剂替米考星和头孢噻呋进行了抗金黄色葡萄球菌乳腺炎测试。在所测试的剂量和持续时间下,这两种产品都不能作为泌乳牛的有效治疗。替米考星的注射或输注以及头孢噻呋的输注均导致牛奶中细菌的减少。然而,仅输注了替米考星的四分之一治愈了,其他疗法均未见治愈。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号